Jeroen FJ Bogie, Elien Grajchen, Elien Wouters, Bieke Broux, Piet Stinissen, Bart Van Wijmeersch, & Jerome JA Hendriks. (2020). CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis. SAGE Publishing.
Chicago Style (17th ed.) CitationJeroen FJ Bogie, Elien Grajchen, Elien Wouters, Bieke Broux, Piet Stinissen, Bart Van Wijmeersch, and Jerome JA Hendriks. CNS Delivery of Anti-CD52 Antibodies Modestly Reduces Disease Severity in an Animal Model for Multiple Sclerosis. SAGE Publishing, 2020.
MLA (9th ed.) CitationJeroen FJ Bogie, et al. CNS Delivery of Anti-CD52 Antibodies Modestly Reduces Disease Severity in an Animal Model for Multiple Sclerosis. SAGE Publishing, 2020.
Warning: These citations may not always be 100% accurate.